Soft-tissue sarcoma in Japan: National Cancer Registry-based analysis from 2016 to 2019
Japanese Journal of Clinical Oncology · 2024
DOI: 10.1093/jjco/hyae088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Clinical Oncology, 2024. Verfasst von Koichi Ogura und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Musculoskeletal Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. Hauptthemen laut MEDLINE: Registries, Sarcoma. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: National Cancer Center Research and Development Funds.
Abstract (Originalsprache)
Background
No previous reports have characterized national profiles of soft-tissue sarcoma overall. We examined the nationwide statistics for soft-tissue sarcoma in Japan using data from the population-based National Cancer Registry.
Methods
We identified 23 522 soft-tissue-sarcoma patients who were entered in the National Cancer Registry during 2016–19 using International Classification of Diseases-Oncology, Third Edition codes for cancer topography and morphology. We extracted data on patient demographics, tumor details (reason for diagnosis, tumor location, histology, extent of disease), hospital volume/type, treatment, and prognosis for each patient.
Results
Soft-tissue sarcoma showed a slight male preponderance. Approximately 5500–6000 new cases were diagnosed as soft-tissue sarcoma per year, with the age-adjusted incidence of soft-tissue sarcoma being 3.22/100000/year. The age distribution showed a single peak in the 70–79 age range, and sex-stratified data showed it was higher in men. The most common histologic subtype was liposarcoma. The most frequent tumor locations were the soft tissue and skin, followed by the retroperitoneum. Extent of disease was categorized as: “localized” (31.3%), “regional” (38.9%), or “distant” (10.5%). We found significant associations between overall survival and sex, age, tumor location, facility type, hospital volume, reason for diagnosis, extent of disease, and surgical treatment.
Conclusions
This is the first study to outline the epidemiology, clinical features, treatment, prognosis, and significant factors affecting prognosis of soft-tissue sarcoma in Japan using the National Cancer Registry. Documenting our data regarding elderly patients’ outcomes is essential so other countries showing similar population-aging trends can learn from our experiences. Level of evidence Prognostic studies, Level III.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Musculoskeletal Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
- Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
- Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba 277-8577, Japan.
- Rare Cancer Center, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
- Division of Health Services Research, Center for Cancer Control and Information Services, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
ORCID-Profile: Shintaro Iwata, Toshiyuki Takemori, Eisuke Kobayashi, Takahiro Higashi
Förderung
- National Cancer Center Research and Development Funds
Zitieren
APA
Ogura, K., Morizane, C., Satake, T., Iwata, S., Toda, Y., Muramatsu, S., Takemori, T., Kondo, H., Kobayashi, E., Katoh, Y., Higashi, T., & Kawai, A. (2024). Soft-tissue sarcoma in Japan: National Cancer Registry-based analysis from 2016 to 2019. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyae088
Vancouver
Ogura K, Morizane C, Satake T, Iwata S, Toda Y, Muramatsu S, et al. Soft-tissue sarcoma in Japan: National Cancer Registry-based analysis from 2016 to 2019. Japanese Journal of Clinical Oncology. 2024. doi:10.1093/jjco/hyae088
BibTeX
@article{Ogura2024,
author = {Ogura, Koichi and Morizane, Chigusa and Satake, Tomoyuki and Iwata, Shintaro and Toda, Yu and Muramatsu, Shudai and Takemori, Toshiyuki and Kondo, Hiroya and Kobayashi, Eisuke and Katoh, Yoko and Higashi, Takahiro and Kawai, Akira},
title = {Soft-tissue sarcoma in Japan: National Cancer Registry-based analysis from 2016 to 2019},
journal = {Japanese Journal of Clinical Oncology},
year = {2024},
doi = {10.1093/jjco/hyae088}
}
EUVIMED